Sleep Disorders Trial, Recruiting NCT05414357 Sponsor: Centre Francois Baclesse Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT05414357
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 39 and 69 years old
  • People who have had surgery for breast cancer that has not spread, and who may or may not be starting chemotherapy after surgery
  • People who have completed at least the end of primary school education
  • People who have a good level of French language skills
  • People who have access to the internet from a computer at home
  • People who have signed a consent form agreeing to take part in the study
  • People who had no existing memory or thinking problems at the time their cancer was diagnosed
  • People who are experiencing sleep difficulties (based on a specific sleep questionnaire score) (confirm with trial site)

Who may not be able to join:

  • People whose cancer has spread to other parts of the body (metastatic cancer)
  • People whose main cancer is not breast cancer
  • People who have a history of neurological damage (damage to the brain or nervous system)
  • People who are currently being treated for sleep apnea
  • People who use drugs or drink alcohol heavily (averaging 3 or more drinks per day, or more than 10 drinks per week)
  • People whose medication for sleep, anxiety, or depression has not been at a stable dose for at least 3 months
  • People who have a personality disorder or an ongoing psychiatric condition
  • People who cannot have an MRI scan — for example, due to claustrophobia or having metal objects in the body
  • People who have an uncorrected vision problem

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33 2 31 45 50 02

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Francois Baclesse
Registry
ClinicalTrials.gov
Start date
20 March 2023
Est. completion
1 March 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Ratio of total sleep time to time spent in bed and the number of awakenings lasting more than one minute measured by polysomnography with actimeter; Amplitude of activity-rest rhythm measured with actimeter; Acrophase of activity-rest rhythm measured with actimeter

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov